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ABSTRACT 
Objective: A marketed product Dr. Ortho has been used by many patients and is gaining a positive feedback from the patients. A study is designed 
to establish its mechanism of action on various anti-rheumatic models in experimental animals. No studies have been investigated on this product 
for its anti-rheumatic activity.  
Methods: Dr. Ortho (55 mg/kg, p. o.) was administered during adjuvant-induced arthritis, phlogistic agents (Histamine, bradykinin, and serotonin) 
induced paw edema, Acetic acid induced writhing test in mice, and Eddy’s hot plate. Histopathology (T. S. of knee joint) and various hematological 
parameters (WBC’s, RBC’s, and ESR count) were observed during the study.  
Results: Dr. Ortho decreases arthritis induced inflammation by antagonizing or inhibiting the inflammatory mediators, i.e., histamine, 5-hydroxy 
tryptamine and bradykinin. (20% (P<0.05) of carrageenan, 10.01%, (P<0.05) of histamine, 8% (P<0.05) of 5-hydroxy tryptamine induced paw 
volume). Dr. Ortho acts as both peripheral and central analgesic. Histopathology findings revealed that there is a reduction in the neutrophil 
infiltration, pannus formation, and bone. Hematological parameters show that Dr. Ortho decreases the elevated level of the WBC’s count.  
Conclusion: The present study revealed some facts regarding the mechanism of Dr. Ortho in reducing arthritis induced inflammation. However 
study may be done further to illustrate its complete mechanism.  
Keywords: Ortho, Adjuvant induced arthritis, Carrageenan, Histamine. 
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INTRODUCTION  
Rheumatoid arthritis (RA) is a systemic, chronic inflammatory 
disease affecting many tissues, but principally attacking the joints to 
produce a non-suppurative proliferative synovitis that frequently 
progresses to destroy articular cartilage and underlying bone with 
resulting disabling arthritis. 
RA is a very common condition, with a prevalence of approximately 
1%; it is three to five times more common in women than in men. 
The peak incidence is in the second to fourth decades of life, but no 
age is immune [1]. The disease affects systemically many extra-
articular tissues, includes skin, blood vessels, heart, lungs and 
muscles [2]. The commonly used drugs such as nonsteroidal anti-
inflammatory drugs (NSAIDS) and biologic (e. g., antitumor necrosis-
α antibody) are effective in alleviating the symptoms of the disease. 
However, the prolonged use of these drugs is associated with severe 
adverse reactions, In addition, these drugs are expensive, and not all 
patients respond well to them. In view of these limitations, it is 
essential to continue the search for safer and less expensive 
alternatives to the conventionally used drugs In fact; herbal plants 
are being used widely as medicine around decades for the treatment 
of arthritic disease. Herbal medicine constitutes important resources 
for the treatment of various ailments [3]. Natural plant products 
represent a promising group of therapeutic agents for arthritis. 
However, one of the major concerns in seriously considering these 
products for therapeutic purposes is that the mechanisms of action 
of many of them are poorly defined, if at all [4,5]. 
Alternate medicines like Ayurveda, Unani, Chinese, etc. are more and 
more used for the treatment of diseases, illness prevention and 
maintenance of health. An ayurvedic polyherbal formulation named-
Dr. Orthocapsules, SBS biotech, Ambala city, Haryana (India) 
containing extracts of different herbal medicinal plants-Boswellia 
Serrata (Shallaki), Commiphora Mukul (guggal), Pluchea Lanceolata 
(Rasna), Trigonella foenumgraecum (Methi), Zingiber Officinale 
(ginger), Withania Somnifera (Ashwagandha powder), Purified 
Asphaltam (shilajeet) and Strychnos Nux-vomica. The constituents 
of this capsule are used in folk medicine for the treatment of 
inflammation and pain associated with arthritis. Therefore, the 
present study was done to determine the mechanism of Dr. Ortho 
capsule. 
MATERIALS AND METHODS 
Animals 
Adult wistar albino rats (180-230 g) of either sex or Swiss albino 
mice (25-30 g) were used for pharmacological activities. For both 
experiments, the animals were kept in polypropylene cages (3 per 
cage) at 25±2 o
Drugs and chemicals 
C with relative humidity 45-55% under 12h light and 
dark cycles. All the animals were acclimatized to laboratory 
condition for a week before use. They were fed with standard animal 
feed and water ad libitum. The Institutional Animal Ethics 
Committee approved the experimental protocols, Reg no. 
837/AC/04/CPCSEA. 
The Dr. Ortho capsule was obtained from SBS Biotech, Himachal 
Pradesh (manufacturing unit). Indomethacin from Sigma-Aldirich. 
Complete Freund’s Reagent, histamine, 5-hyrdoxy tryptamine, 
bradykinin, carrageenan from Sigma Aldirich. AST, ALT and TP kits 
for estimation were obtained from Transasia bio-medicals limited, 
Mumbai (India). 
Anti-arthritic activity–adjuvant induced arthritis in rats [6] 
Albino rats weighing 150-200 g were divided into four groups of six 
animals. Controls animals were administered the vehicle. Group 2 
(Arthritic control) animals were injected with CFA 0.1 ml to 
subplantar region of right hind paw, For Group 3 and Group 4 
animals, respectively, Dr. Orthocapsule (55 mg/kg, p. o.) and 
indomethacin (10 mg/kg, p. o.) were administered twice a day, from 
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the day of injection of CFA (0.1 mL in the subplantar region) and 
continued up to 14th post CFA challenge day. Paw volume was 
measured using a mercury plethysmograph on 0, 4, 7, 14, 21 d from 
the day of CFA injection [7]. At the end of the 21st day, blood was 
withdrawn from retro-orbital plexus, WBC count was found, and 
serum was separated by centrifugation (Remi) at 3000 rpm for 15 
min. [8]. Estimation of ALT, AST and total protein [9] were done 
using standard Erba-chem kits, Germany (marketed by Transasia 
medico labs, Mumbai, India) and auto analyzer. Histopathological 
assessment of the knee joint was done on the 21st day after 
euthanasia. The groups defined to be:  
Group 1: Control 
Group 2: CFA-induced (0.1 ml) 
Group 3: Dr. Ortho (55 mg/kg, p. o.) 
Group 4: Indomethacin (10 mg/kg, p. o.) 
Anti-inflammatory activity–phlogistic agents induced paw 
edema in rats [10, 11] 
Male Albino Wistar rats weighing between 150-200 g were divided 
into twelve groups of six rats each. Animals of Group 1 receive 
vehicle (distilled water 10 ml/kg p. o.), animals of groups were 
subjected to inflammation by injecting phlogistic agents prior to 
administration of the vehicle. Groups of animals were administered 
with poly herbal formulation (55 mg/kg p. o.) followed by 5-HT [0.1 
ml (1 mg/ml)], bradykinin [0.1 ml (20 µg/ml)] 60 min thereafter and 
carrageenan [0.1 ml (1%)], histamine [0.1 ml (1 mg/ml)] 30 min 
thereafter animals of the group were also administered with 
indomethacin (10 mg/kg, i. p.) followed by respective phlogistic 
agents. The following was the groups prepared- 
Group 1: Histamine [0.1 ml (1 mg/ml)] 
Group 2: Dr. Ortho (55 mg/kg, p. o.)+histamine  
Group 3: Indomethacin (10 mg/kg, p. o.)+histamine 
Group 4: 5-hydroxy tryptamine [0.1 ml (1 mg/ml)] 
Group 5: Dr. Ortho (55 mg/kg, p. o.)+5-hydroxy tryptamine  
Group 6: Indomethacin (10 mg/kg, p. o.)+5-hydroxy tryptamine 
Group 7: Carrageenan (0.1 ml (1%)] 
Group 8: Dr. Ortho (55 mg/kg, p. o.)+Carrageenan 
Group 9: Indomethacin (10 mg/kg, p. o.)+Carrageenan 
Group 10: Bradykinin [0.1 ml (20 µg/ml)] 
Group 11: Dr. Ortho (55 mg/kg, p. o.)+Bradykinin 
Group 12: Indomethacin (10 mg/kg, p. o.)+Bradykinin 
The paw volumes were measured immediately (0 h) and then at 
predetermined intervals; for Carrageenan at (30 min, 1 h, 2 h, 3 h, 4 
h, 5 h, and 6 h), for Bradykinin at (10 min, 20 min, 30 min, 60 min, 
and 120 min), for Histamine and 5-HT at (30 min, 60 min, 90 min, 
120 min, 150 min, and 180 min) using plethysmometer. Percent 
change in paw volume was calculated using the following formula. 
%Inhibition = 100-(Control mean/Treated mean x 100) 
Analgesic activity 
Acetic acid induced writhing test in mice [12]  
Mice of either sex with a weight between 20 and 25 g are used. 
Three groups were made, one group treated as a control and 
received 0.6% v/v acetic acid i. p., second one received diclofenac 
sodium (20 mg/kg, p. o.) as a standard drug and the last group was 
given Dr. Ortho (55 mg/kg, p. o.).  
Group 1: Control (0.6% v/v acetic acid, i. p.) 
Group 2: Diclofenac sodium (20 mg/kg, p. o.) as standard  
Group 3: Dr. Ortho (55 mg/kg, p. o.) 
Test animals are administered the drug or the standard at various 
pretreatment times prior to acetic acid administration. The mice are 
placed individually into glass beakers and five min are allowed to 
elapse [13]. The mice are then observed for a period of 10 min and 
the number of writhes is recorded for each animal. The formula for 
computing percent inhibition is- 
 
Eddy’s hot plate 
Three groups of six mice each of either sex with an initial weight of 
18 to 22 g are used for each dose. The hot plate, which is 
commercially available, consists of an electrically heated surface. 
The temperature is controlled for 55 ° to 56 °C. This can be a copper 
plate or a heated glass surface. The animals are placed on the hot 
plate and the time until either licking or jumping occurs is recorded 
with a stopwatch. The latency is recorded before and after 20, 60 
and 90 min following oral or subcutaneous administration of the 
standard or the test compound [14]. The three groups are as 
follows- 
Group 1: Control  
Group 2: Tramadol (25 mg kg_1, p. o.), as standard 
Group 3: Dr. Ortho (55 mg/kg, p. o.) 
Histopathology 
After euthanasia on day 21, the hind paws amputated above the 
knee joint were fixed in 7.4% formalin solution. The sections of 
articulation of the tarsal joints were stained with haematoxylin and 
eosin and were examined microscopically for mononuclear 
infiltration, pannus formation, and bone destruction [15]. 
Statistical analysis 
All the results were expressed as mean±SEM and analysis were 
carried out by one-way ANOVA, Post-hock analysis was done by 
Tukey’s multiple comparison tests to estimate the significance of the 
difference between various individual groups. P<0.05 was 
considered as significant. 
Evaluation of parameters 
Body weight changes were measured by an electronic weighing 
balance. Haematological parameters like RBC, Hb (hemoglobin), ESR, 
and WBC was measured by Autoanalyzer [16]. 
RESULTS 
Anti-arthritic activity–adjuvant induced arthritis in rats 
Paw volume 
Dr. Ortho decreased the paw volume on day 4, 7, 14, and 21 
respectively as shown in table 1. 
Lysosomal enzymes 
Dr. Ortho decreased (but not significant) the lysosomal enzyme ALT, AST 
and total protein compared with arthritic rats, as shown in the fig. 2. 
Histopathological study 
Section of the synovial joint of a normal control rat shows intact 
articular hyaline cartilage (fig. 3(A), subchondrial bone layer and 
adjacent synovial layer. The synovial layer shows synovial lining 
cells within a normal range. The synovial subepithelium shows 
fibro-collagenous stroma with vascular spaces (fig. 3 (A)). Section of 
the synovial joint of CFA treated rat shows partially distorted 
articular hyaline cartilage with intact subchondrial bone layer and 
partially effaced synovial layer. The distorted articular cartilage, i.e., 
bone erosion is replaced by mixed inflammatory cells comprising 
predominantly neutrophil and some lymphocytes. The synovial sub 
epithelium shows fibro collagenous stroma with vascular spaces (fig. 
3 (B)). Section of the synovial joint of Dr. Ortho treated shows intact 
articular hyaline cartilage (fig. 3 (C)), subchondrial bone layer and 
adjacent synovial layer. The synovial layer shows synovial lining 
cells within normal range. The synovial sub epithelium shows 
fibrocollagenous stroma with vascular spaces (fig. 3 (C)). 
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Table 1: Effect of Dr. Ortho on paw edema 
Treatment Paw volume (ml) (mean±sem)  
0 d 4th 7 day th 14 day th 21 day st   day 
Control 1.23±0.01 1.37±0.034 1.17±0.086 1.26±0.0140 2.10±0.034 
CFA 1.1±0.037 2.77±0.054 3.2±0.041** 2.9±0.037*** 2.5±0.044** 
Dr. Ortho 
* 
1.2±0.031 2.5±0.043 2.5±0.023 2.10±0.037 1.70±0.033 
Indomethacin  1.21±0.022 2.50±0.013 2.53±0.021 2.10±0.019 1.70±0.080 
Values are expressed as mean±SEM n= 6; one way ANOVA followed by Turkey’s test, ***p<0.001 v/s control, **p<0.01 and *
 
p<0.05 v/s control. 
 
Fig. 1: Effect of Dr. ortho on paw edema  
Values are expressed as mean±SEM. n=6; One-way ANOVA 
followed by TURKEY’s multiple comparison test. ***P<0.001 vs 
control, **P<0.01 vs arthritic control, *
 
P<0.05 vs arthritic control 
Fig. 2: Effect of Dr. ortho on AST and ALT  
Values are expressed as mean±SEM. n=6; One-way ANOVA 





Fig. 3: (A)-TS of the knee joint of normal control rat, showing no mononuclear infiltration and pannus formation [H&E, 100×]. (B)-TS of 
the knee joint of with bone erosion [H&E, 400×]. (C)-TS of knee joint of with reduced bone erosion [H&E, 100×] 
 
Anti-inflammatory activity–phlogistic agents induced paw 
edema in rats 
Dr. Ortho significantly reduced the Carrageenan (fig. 4), Histamine (fig. 
5), 5-HT (fig. 6), Bradykinin (Fig.7) induced paw edema respectively. 
 
 
Fig. 4: Effect of Dr. Ortho on carrageenan-induced paw edema in rat 
Values are expressed as mean±SEM. n=6; One-way ANOVA 





Fig. 5: Effect of Dr. Ortho on histamine-induced paw edema in rat 
Values are expressed as mean±SEM. n=6; One-way ANOVA 
followed by TURKEY’s multiple comparison test. **P<0.01 vs 
arthritic control, *
 
P<0.05 vs arthritic control. 
Analgesic activity 
Acetic acid induced writhing test in mice 
Dr. Ortho when compared to control animals, significantly (P<0.01) 
decreased the number of acetic acid induced writhing episodes and 
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the percentage protection was 41.2%, while the reference drug, 
Diclofenac sodium showed 66.4% protection. 
Eddy’s hot plate 
Fig. 8 shows the time interval of the anti nociception produced by 
Dr. Ortho. The effect reached a peak significantly at 120 min after 
administration and then gradually decreased. 
 
 
Fig. 6: Effect of Dr. Ortho on 5-HT induced paw edema in rat 
Values are expressed as mean±SEM. n=6; One-way ANOVA 
followed by TURKEY’s multiple comparison test. **P<0.01 vs 
arthritic control, *
 
Fig. 7: Effect of Dr. ortho on bradykinin-induced paw edema in rat 
Values are expressed as mean±SEM. n=6; One-way ANOVA 
followed by TURKEY’s multiple comparison test. 







Fig. 8: Analgesic activity of Dr. Ortho using Eddy's hot plate 
Values are expressed as mean±SEM n=6; One-way ANOVA 
followed by TURKEY’s multiple comparison test. *
In the present study an attempt is made to illustrate mechanism of 
the action of Dr. Ortho. Inflammation, pain and pannus formation are 
the integral parts of arthritis. Hence, we tried to elucidate the 
mechanism of action of Dr. Ortho by studying its effect on these 
three components. Inflammation, an integral part of arthritis, causes 
various abnormalities like swelling, redness, loss of function through 
numerous mediators like Cytokines, Bradykinin, Histamine, 
Eicosanoids, and Platelet activating factor. So in our study, we 
selected some of the known phlogistic agents like Carrageenan, 
Histamine, 5-HT and Bradykinin to understand the anti-
inflammatory component of Dr. Ortho. Adjuvant-induced arthritis in 
rats is the most widely used models of experimental arthritis in 




Body weight changes 
Dr. Ortho (55 mg/kg) inhibits the loss of body weight observed 
during arthritic condition in a disease control group. The results are 
shown in table 2. 
Hematological changes 
Dr. Ortho and indomethacin-treated groups significantly decreased 
the total WBC count while ESR count regains its normal value. The 
results are shown in table 3. 
DISCUSSION  
Table 2: Changes in body weight in adjuvant arthritis in rats 
S. No. Groups Before treatment(g) After treatment on 21st Mean change in body weight  day(g) 
1. Control 172.1 173.9 1.8±0.150 
2. CFA induced 167.3 160.1 -7.2±0.25
3. 
# 
Dr. Ortho 169.5 171.0 1.5±0.135 
4. Indomethacin 174.7 176.4 1.7±0.605 
 
Table 3: Effect on hematological parameters in adjuvant induced arthritis in rats 
S. No. Treatment Total WBC count cells/μl RBC count (million/μl) Hb (g%) ESR (mm/h) 
1 Control 8102.6±0.6 6.45±0.191 10.23±0.11 12.75±0.01 
2 CFA induced 14002.6±214 4.14±0.046** 10.82±0.15 17.26±0.22 
3 Dr. Ortho 7597±8.57 5.09±0.17 10.20±0.002 6.27±0.28 
4 Indomethacin 6057.4±8 7.19±0.11 12.11±0.11 6.02±0.15 
All values are in mean±SEM **P≤0.03 is considered significant, *p<0.0001 considered more significant when compared to the control (n=6) 
 
We found that Dr. Ortho inhibited 20% (P<0.05) of Carrageenan-
induced paw volume at 30 min., 10.01%, (P<0.05) of Histamine 
induced paw volume at 30 min respectively. 8%, 7% (P<0.05) of 5-
HT induced paw volume at 30 min and 120 min. 3% (P<0.01) of 
Bradykinin-induced paw volume at 20 min. respectively. These 
results show that, though not very potent, Dr. Ortho decreased the 
inflammation by antagonizing or inhibiting the inflammatory 
mediators i.e., Histamine, 5-HT and Bradykinin. Analgesic activity of 
Dr. Ortho was illustrated through, acetic acid induced; 
prostaglandins mediated pain, where percentage protection was 
found to be 45.1% (P<0.001). Analgesic activity of Dr. Ortho using 
Eddy’s hot plate was found to be maximum of 120 min. This 
indicates that Dr. Ortho acts as both peripheral and central 
analgesic. 
Pannus formation is one of the major events which lead to cartilage 
destruction and bone erosion in rheumatoid arthritis. The pannus 
formed due to CFA was reduced by Dr. Ortho. It is supported by 
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histological studies of knee joints [18]. fig. 3 (A) is TS of knee joint of 
control rat. Severe neutrophil infiltration, pannus formation and 
bone erosion are seen in the knee joint of arthritic control rat as 
shown in fig. 3 (B). On treatment with Dr. Ortho, there is a reduction 
in the neutrophil infiltration, pannus formation and bone as shown 
in fig. 3 (C), respectively. Loss of body weight occurs in arthritis due 
to deficient absorption of nutrients through the intestine and 
distress caused by the severity of arthritis [19]. Dr. Ortho decreased 
the elevated level of WBC, thus leading to a reduction in 
mononuclear infiltration and hence reduced pannus formation. 
CONCLUSION 
The ayurvedic product is purely based on ancient Indian data for the 
treatment of the pain coupled with arthritis. The study was taken up 
with an aim to explicate the mechanism of the anti-arthritic action of 
the mentioned polyherbal product. 
In summary, the anti-rheumatic mechanism of Dr. Ortho is due to- 
I. Inhibition of inflammation by inhibiting inflammatory mediators, 
i.e., Histamine, 5-HT, and Bradykinin. 
II. Protection against prostaglandins mediated pain in mice, by 
inhibiting cyclo-oxygenase synthesis. 
III. Reduction in pannus formation by inhibiting mononuclear 
infiltration. 
Therefore, the data clearly indicate the antiarthritic action of a 
polyherbal formulation. 
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